Petersham, MA, United States of America

Louis P Kertiles



Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003-2005

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Louis P. Kertiles: Innovator in Antibody Detection

Introduction

Louis P. Kertiles is a notable inventor based in Petersham, MA (US). He has made significant contributions to the field of antibody detection, particularly in relation to glycosphingolipids and gangliosides. With a total of 3 patents, Kertiles has developed innovative methods that have implications for diagnosing autoimmune diseases and neuropathies.

Latest Patents

Kertiles' latest patents include groundbreaking methods for detecting antibodies to glycosphingolipids. One patent describes a technique that utilizes solid-phase reactants coated with carbonyl groups. This method links glycosphingolipids of interest to the solid-phase reactant via an amide bond, allowing for effective detection of antibodies. This innovation can be instrumental in diagnosing autoimmune diseases in individuals. Another patent focuses on detecting antibodies to gangliosides using a similar approach. This method also employs solid-phase reactants with carbonyl groups, facilitating the diagnosis of neuropathies through the detection of specific antibodies.

Career Highlights

Kertiles is currently associated with Athena Diagnostics, Inc., where he continues to advance research in antibody detection. His work has been pivotal in enhancing diagnostic methods that can lead to better patient outcomes.

Collaborations

Kertiles collaborates with Normand J. Robichaud, contributing to the innovative research environment at Athena Diagnostics, Inc. Their combined expertise fosters advancements in the field of diagnostics.

Conclusion

Louis P. Kertiles stands out as an influential inventor in the realm of antibody detection. His innovative patents and ongoing work at Athena Diagnostics, Inc. highlight his commitment to improving diagnostic methods for autoimmune diseases and neuropathies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…